INTRODUCTION
Telomeres are specialized nucleoprotein structures located at the extremities of linear chromosomes. Due to the incapability of conventional DNA polymerases to fully replicate the far end of the chromosome, telomeres become shortened every time the cell divides until they reach a critical length that causes genetic instability [1] [2] [3] [4] . Thus, telomeres serve as a molecular clock regulating the lifespan of each cell. Telomeres must be elongated to prevent the cells from entering cellular senescence. This happens through the actions of an enzyme called telomerase, which is a reverse transcriptase with the ability to synthesize telomeric sequences. It consists of two components: the RNA component (hTR), which serves as a template and is complementary with the telomere; and the catalytic subunit (hTERT), which is a reverse transcriptase that synthesizes telomeric DNA, having its own RNA as a template [5] [6] [7] [8] . Though this enzyme is highly upregulated during development and differentiation, in mature organisms, it becomes inactive in almost every somatic cell. Some cell types, including lymphocytes, are an exception to this rule. They exhibit telomerase activity during adult life [5] . Many studies have found that the RNA component is expressed in many types of cell in mature organisms, and proper telomerase activity seems to depend on strongly on the expression of hTERT [7, 9] . Many studies suggest that the minimal requirement for the normal activity of telomerase in vitro is the expression of both hTR and hTERT. However, the common belief is that the regulation and proper activity of telomerase in vivo is complex, multistep procedure that involves many other proteins as well [10] [11] [12] [13] . When the telomere length reaches a critical point, the RNA component (hTR) provides the template and then the reverse transcriptase (hTERT) synthesizes DNA with its own RNA unit as the source. Thus, a single-strand overhang is produced. The common DNA polymerase then synthesizes the complementary strand after the dissociation of the telomerase holoenzyme [10] [11] [12] [13] [14] . This produces the telomere, a specialized DNA structure that gathers a plethora of proteins. In normal human somatic cells, a telomere consists of 8-12 kb of double-strand 5' TTAGGG 3', repeated tandemly hundreds of times and terminating in a single-strand (ss) 3' overhang of 100-200 nucleotides of the G-rich sequence [12, [15] [16] [17] . There have been numerous scientific reports showing that chronic inflammation is a major problem for dialysis patients. One major cause of death in this group of patients is cardiovascular disease, which can be caused and/or accelerated by chronic inflammation. A state of chronic inflammation is evident when either elevated pro-inflammatory cytokines (IL-1β, IL-6, TNF-a, etc.) or elevated acute phase proteins (CRP, albumin, fetuin-A, etc.) are present [18] [19] [20] . Though many researchers have shown that dialysis patients suffer from chronic inflammation, the pre-dialysis stages do not appear to have been well investigated in terms of inflammation [18] . No one can be certain of the real causes of chronic inflammation, but there has been considerable speculation, such as improper clearance of antigens and cytokines as the glomerular filtration rate (GFR) declines; urea and its by-products; dialysis membranes; and oxidative stress [19] [20] [21] . In recent years, anti-inflammatory therapy for such patients has gained wide recognition as having many potent beneficial effects [22] [23] [24] . Since telomerase is active in mature lymphocytes, its role must be essential to the host's defense and immune system response. The aim of this study was to determine if there is a difference in telomerase activity between chronic kidney disease patients (CKD), dialysis patients and normal healthy controls, and to investigate if there are any indications that telomerase activity might be connected with the inflammatory status of the populations. The activity of this enzyme was assessed at the protein and transcription levels, since expression of hTERT was also determined by means of the relative quantification technique.
MATERIALS AND METHODS

Ethics statement
The Ethics Committee of the General Hospital of Athens, G. Gennimatas, approved this research project Written informed consent was obtained from all the subjects.
Patients and healthy control subjects
The population of the study consisted of three groups: 53 healthy individuals (the control group), 50 individuals with chronic kidney disease not undergoing dialysis (the CKD group), and 50 patients undergoing hemodialysis several times a week (the dialysis group). All the subjects were Greek. Their age, sex, GFR and other data are shown in Table 1 . Interviews were conducted with the subjects before their admission to the study. Subjects were defined as smokers or non-smokers. A fasting plasma glucose value of > 126 mg/dl was used as the definition of diabetes, as per the guidelines of the American Diabetes Association [25] . Hypertension was defined through a blood pressure mean value of > 140/80 mm Hg or anti-hypertensive treatment. Table 1 . Characteristics of the study population (n = 153). The numbers in each column represent a positive statement. For example 4 out of the 53 healthy controls had diabetes and 15 out of the 50 dialysis patients were taking beta blockers.
Atherosclerosis was identified as a history of angina and/or vascular interventions, or a history of any cardiovascular event (e.g., past myocardial infarction). The New York Heart Association definitions were used to assess heart failure in the population studied. The control group consisted of hospital staff members, members of their families and their friends. The CKD group included patients with a declined renal function and decreased GFR (GFR values from 15 to 60 ml/min, calculated with the Cockcroft-Gault formula), but without indication of dialysis sessions. The dialysis group consisted of patients with totally diminished kidney function who were undergoing dialysis several times a week. The mean time that these patients were in dialysis was 72.7 months (SD 65.8 filter was made from cellulose, while for 16 patients a synthetic filter was used. In 39 patients the vascular access was a fistula, in 6 patients a graft, and in 5 patients a temporary catheter.
Blood sample collection
In all of the groups a 15-ml heparinized blood sample and a 5-ml nonheparinized blood sample were collected for the PBMC and serum samples. In dialyzed patients, blood samples were drawn just before the start of the midweek dialysis session.
Preparation of PBMCs
PBMCs were obtained using Ficoll-Hypaque (Histopaque 1077, Sigma Aldrich) gradient density centrifugation (400 g for 30 min). The mononuclear layer was then collected and washed 3 times in PBS, and finally an aliquot containing 2 x 10 5 cells (for telomerase detection) was transferred into Eppendorf tubes. For later examination the 2 x 10 5 cells were centrifuged at 3,000 g for 5 min at 8ºC and the pellet was stored at -80ºC until needed. The remaining cells were used for RNA purification. The viability of PBMCs was determined by trypan blue dye exclusion at the end of each culture. More than 85% of the cells were found to be viable.
Detection of telomerase activity
Telomerase activity was measured using a commercial telomerase PCR-ELISA kit (Roche Diagnostics Corporation), based on the telomeric repeat amplification protocol (TRAP) method described by Kim et al. [26] . Telomerase activity was expressed in optical density values (OD). Immortalized telomerase-expressing human kidney cells (293) were used as the positive control. Samples that had undergone inactivation of the telomerase protein at 85ºC for 10 min were used as the negative control. PCR without the sample was used as the PCR control. The cells were measured before each TRAP experiment and exactly 2 x 10 5 PBMCs were used per reaction. Telomerase activity was measured as an optical density value and calculated in the PBMCs from 153 individuals totally.
Quantification of hTERT using real-time PCR RNA was purified from PBMCs using Macherey-Nagel's KG NucleoSpin 96 RNA kit according to the manufacturer's instructions. Reverse-transcription PCR (RT-PCR) was performed on purified RNA samples with Superscript III Reverse Transcriptase from Invitrogen as described in the product's instruction sheet. 4 x 10 6 cells per sample were used for the RNA purification. An aliquot of 11.5 μl from the isolated RNA was used per sample, and the resulting cDNA was used in real-time PCR. This was performed on an SDS System 7300 (Applied Biosystems) and an Assays-On-Demand 20x assay mix of primers and FAM dye-labeled TaqMan MGB probes (Applied Biosystems) were employed to calculate the relative expression of hTERT (Assay ID: Hs99999022_m1). Predeveloped GAPDH (glyceraldehyde 3-phosphate dehydrogenase -a "housekeeping" gene) TaqMan assay reagent was used as an endogenous control. The cycling parameters and experimental procedures were those given by the manufacturer. Each experiment was performed under the same conditions in duplicate. To avoid any bias, RNA isolation and real-time PCR experiments were performed with multiple samples simultaneously and the samples were categorized with respect to the group that each belonged to, after each reaction was completed.
The Ct values obtained at the end of the procedure were transferred to REST (Relative Expression Software Tool, v2.0.7, copyright 2008, Corbett Research Pty. Ltd.) for calculation of the relative expression. Since the relative quantification method was used to assess the gene transcription rates, only pairwise comparisons could be made. These comparisons are shown in Table 2B , along with the differences in expression, the difference factor and the statistical significance. The term difference in expression stands for the difference in gene expression between the two groups. Ct values calculated from the real-time PCR experiments were analyzed using REST software with the first group in each pair always being considered as the control group, while the second one was the group to be tested. The result of this comparison shows the difference in expression between two conditions. Difference factor means the increase or decrease of the expression in folds. For example, if the result between two groups is a downregulation of hTERT by a factor of 0.1, then the second group exhibits a tenfold decrease in hTERT expression when compared to the first group. Ten samples from each group were randomly selected for the expression analysis. Table 2 . Telomerase activity and expression in the population studied.
CRP and cytokine assays
Blood serum was isolated by centrifugation of the 5-ml non-heparinized blood vial in 3200 rpm for 25 min. The quantitative determination of CRP was assayed via routine particle-enhanced immunonephelometry on a Behring Nephelometer 2. The high-sensitivity CRP assay was designed to measure CRP concentrations within an overall range of approximately 0.175-1.100 mg/l. IL-6, IL-10 and TNF-a serum levels were quantified with a sandwich enzyme immunoassay technique, based on a monoclonal-polyclonal antibody pair (R&D Systems). All of the reactions were carried out according to the manufacturer's instructions. CRP and cytokine concentrations were calculated in the blood serum of 153 persons totally.
Statistical analysis
The statistics software was SPSS from IBM. The normality of data and results was tested with the Shapiro-Wilk and Kolmogorov-Smirnova tests. As it turned out, most data did not have a normal distribution so we decided to use nonparametric tests. Telomerase OD values and serum markers were analyzed using the Kruskal-Wallis (K-W) test, while the Dunnett test was employed for telomerase pair-wise comparisons. Levene's statistical test was used to find out if any of the factors shown in Table 1 (diseases, drugs, etc.) had any correlation with telomerase activity and/or the serum inflammation markers measured. The statistical significance of the real-time PCR results was calculated using REST software that uses the hypothesis test through many randomization techniques. Spearman's Rho test was used for the statistical correlations.
RESULTS
This study consisted of 153 individuals divided into three groups: 53 healthy subjects (the control group), 50 patients with kidney failure not undergoing dialysis (the CKD group), and 50 patients with no renal function, undergoing frequent hemodialysis (the dialysis group). The subjects admitted to this study were chosen so that the age and BMI values were similar in each group. Many of the participants were regular smokers while a large proportion of them also suffered from other health issues. The general characteristics, demographic data, chronic conditions and treatments of the population studied are shown in Table 1 . The lowest telomerase activity was found in the CKD group while the control group had the highest telomerase activity. In addition, the control and dialysis groups showed the same expressions of the telomerase reverse transcriptase gene while the lowest levels of expression were again observed in the CKD group. As far as inflammation is concerned, TNF-a serum levels become higher as the disease progresses while IL-6 and CRP are higher in the CKD group. Our extra analyses show that these results are not in any way affected by age, sex, BMI or any other chronic condition or medication. The statistical power of our study as calculated by an online tool by DSS research [27] was 95.2%. The results are described in detail below.
Telomerase activity, hTERT expression and inflammation
Telomerase activity values and their statistical significance are given in Table 2A .
PBMCs from the control subjects exhibited the highest telomerase activity values, while the CKD group subjects had the lowest. The dialysis patients had lower OD values than the controls, but slightly higher values than for the CKD group. In Table 2A , the telomerase activity values are compared with respect to each sample's group (K-W test). The enzyme's activity is also depicted in Fig. 1 , which shows the results from the K-W test and two pairwise comparisons, also performed with the Dunnett statistical test. Table 2A .
The control subjects and dialysis patients exhibited the same level of hTERT transcription, whereas in the CKD group, a 5-fold decrease in its expression was observed when compared to the control group (Fig. 2, Table 2B ). As thoroughly explained in the Materials and Methods section, due to the use of the relative quantification method, the expression level of a given gene is calculated only through pairwise comparisons performed with REST software. This is why there are no numbers in Fig. 2 . The graph is just a visualization of Table 2B . The bars show the differences in expression between the different conditions and their height does not correspond to a certain numerical value. Fig. 2 . Transcription levels of hTERT in every group studied. Ten samples from each category were used and each sample was measured in duplicate. The gene is downregulated in the CKD group (p = 0.047), while its expression remains unchanged in the dialysis group (p = 0.085). The expression comparisons were made with Ct values from healthy subjects as one part of every pair. The statistical significance of the real-time PCR results was calculated using REST software that uses the hypothesis test through many randomization techniques. More data are shown on Table 2B . Table 3 . The mean values of the four markers measured in the serum of the whole population are shown in Fig. 3 , while a detailed analysis is shown in Table 3 . IL-6 and CRP were significantly higher in the CKD group than in the other two groups. The dialysis group also exhibited higher IL-6 and CRP values than the control group, but lower values than the CKD group. TNF-a values became higher as the renal disease advanced. The control group exhibited low values, the CKD group higher and the highest values were measured in the dialysis group. IL-10 values were similar in all three groups. [28] [29] [30] [31] [32] [33] . This is why we wanted to investigate the immune system impairment in these patients from three different points of view: telomerase activity, telomerase gene expression and inflammation status.
Although there are many speculations that inflammation increases mortality and morbidity in renal failure patients, the exact mechanism is poorly understood.
Here we demonstrated that both telomerase activity and expression are affected in patients with a decline in renal function, a fact that might be associated with the increased inflammation markers. These conclusions concur with the results of two previous studies conducted in our laboratory [34, 35] . In addition one cannot overlook the negative statistical relationship between the rise in IL-6 serum concentration and the decrease in telomerase activity. Whether inflammation causes the decline in telomerase activity or the decline in telomerase activity is the cause of inflammation is still not clear. Numerous studies focus on inflammation but most of them target dialysis patients [21, 36] . We believe that more intensive research is needed to identify the possible causal relationship between inflammation and telomerase activity in the primary stages of renal failure. There are occasions where it has been shown that senescence and/or telomere dysfunction trigger inflammatory processes [37] , so perhaps telomerase dysfunction can also cause the increase in many inflammation markers in CKD. On the other hand, Rentoukas et al. [38] observed elevated telomerase activity in PBMCs from patients with metabolic syndrome, while TNF-a and IL-6 were also elevated in the subjects studied. In addition, Ghosh et al. [39] discovered that telomerase directly binds the transcription factor Nf-kB, which is a master regulator of inflammation. NF-kB plays a central role in mediating the actions of TNF-a [40] . In this study, this particular inflammation marker rises in an almost linear course as the disease progresses. Our results, combined with data from the scientific literature, provide strong indications of a telomerase-inflammation association, although more studies are needed in order for this connection to be further elucidated in patients suffering from renal failure and other chronic conditions. Our results answer some questions, but raise many as well. As stated before, it would be really interesting to explore whether our findings are in agreement with the telomeric length of lymphocytes from renal patients. In addition, it would be appropriate to study distinct lymphocyte populations in order to understand the full molecular pathways of possible interaction of inflammation with telomerase biology. Here, we isolated PBMCs, a heterogenic population, via a Ficoll-Hypaque gradient density centrifugation, which is a well-known and established method that also has the advantage of being a cost-effective procedure. Since these cells do not belong to a certain population, we ought to be extremely careful with our conclusions. However, our results provide indications of a strong association between inflammation and the telomeric biology of these patients. We propose that future studies should focus on a) finding certain inflammation markers that may disrupt telomerase activity/expression in distinct types of lymphocytes; b) discovering how these markers possibly affect the telomeric length of these cells; and c) establishing the possible outcome of suppressing these markers. Even if telomerase dysfunction and not inflammation is the triggering event in CKD immune system impairment, it is very likely that the resulting inflammation propels the progress of the disease. Further investigations toward these directions must be carried out in order to determine if the implementation of anti-inflammatory treatment would benefit patients with a decline in GFR.
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